E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/30/2008 in the Prospect News Structured Products Daily.

New Issue: ABN Amro prices $500,000 9.25% reverse convertibles linked to Merck

By Jennifer Chiou

New York, April 30 - ABN Amro Bank NV priced $500,000 of 9.25% Knock-In Reverse Exchangeable Securities due May 6, 2009 linked to Merck & Co., Inc. stock, according to an FWP filing with the Securities and Exchange Commission.

Interest is payable monthly.

Payout at maturity will be par in cash unless Merck stock falls below the protection price of $27.86, 75% of the initial price of $37.14, during the life of the notes and finishes below the initial price, in which case the payout will be a number of Merck shares equal to $1,000 divided by the initial price.

ABN Amro Inc. is the agent.

Issuer:ABN Amro Bank NV
Issue:Knock-In Reverse Exchangeable Securities
Underlying stock:Merck & Co., Inc. (Symbol: MRK)
Amount:$500,000
Maturity:May 6, 2009
Coupon:9.25%, payable monthly
Price:Par
Payout at maturity:Par in cash unless Merck stock falls below the protection price during the life of the notes and finishes below the initial price, in which case 27.86 shares of Merck stock
Initial price:$37.14
Protection price:$27.86, 75% of $37.14
Exchange ratio:27.86
Pricing date:April 29
Settlement date:May 6
Agent:ABN Amro Inc.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.